Peditrace (Fresenius Kabi USA, LLC)
Welcome to the PulseAid listing for the Peditrace drug offered from Fresenius Kabi USA, LLC. This Copper Absorption Inhibitor [EPC],Decreased Copper Ion Absorption [PE],Magnetic Resonance Contrast Activity [MoA],Paramagnetic Contrast Agent [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Fresenius Kabi USA, LLC |
| NON-PROPRIETARY NAME: | ZINC, COPPER, MANGANESE, SELENIUM, FLUORINE, and IODINE |
| SUBSTANCE NAME: | ZINC CHLORIDE; CUPRIC CHLORIDE; MANGANESE CHLORIDE; SODIUM SELENITE; SODIUM FLUORIDE; POTASSIUM IODIDE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Copper Absorption Inhibitor [EPC],Decreased Copper Ion Absorption [PE],Magnetic Resonance Contrast Activity [MoA],Paramagnetic Contrast Agent [EPC] |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | INJECTION, SOLUTION |
| MARKETING CATEGORY NAME: | UNAPPROVED DRUG FOR USE IN DRUG SHORTAGE |
| START MARKETING DATE: | 2013-05-09 |
| END MARKETING DATE: | 0000-00-00 |
Peditrace HUMAN PRESCRIPTION DRUG Details:
| Item Description | Peditrace from Fresenius Kabi USA, LLC |
| LABELER NAME: | Fresenius Kabi USA, LLC |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 250; 20; 1; 2; 57; 1(ug/mL; ug/mL; ug/mL; ug/mL; ug/mL; ug/mL) |
| START MARKETING DATE: | 2013-05-09 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 63323-147_086089e9-b92a-4cd3-9df4-39fbd4ee4704 |
| PRODUCT NDC: | 63323-147 |
| APPLICATION NUMBER: | |
Other ZINC CHLORIDE; CUPRIC CHLORIDE; MANGANESE CHLORIDE; SODIUM SELENITE; SODIUM FLUORIDE; POTASSIUM IODIDE Pharmaceutical Manufacturers / Labelers:
